808 results on '"Pilc, Andrzej"'
Search Results
2. Interaction of hallucinogenic rapid-acting antidepressants with mGlu2/3 receptor ligands as a window for more effective therapies
3. Neurotoxicity in Depression
4. The functional cooperation of 5-HT1A and mGlu4R in HEK-293 cell line
5. Efficacy of single and repeated administration of ketamine in unipolar and bipolar depression: a meta-analysis of randomized clinical trials
6. Simultaneous activation of muscarinic and GABAB receptors as a bidirectional target for novel antipsychotics
7. Nowe podejście naukometryczne do oceny jakości jednostek naukowych na przykładzie Polskiej Akademii Nauk.
8. Depression and schizophrenia viewed from the perspective of amino acidergic neurotransmission: Antipodes of psychiatric disorders
9. Neurotoxicity in Depression
10. New evidences for a role of mGluR7 in astrocyte survival: Possible implications for neuroprotection
11. The potential antidepressant action and adverse effects profile of scopolamine co-administered with the mGlu7 receptor allosteric agonist AMN082 in mice
12. Neurochemical changes underlying schizophrenia-related behavior in a modified forced swim test in mice
13. Potential use of psilocybin drugs in the treatment of depression
14. The Potential of Scopolamine as an Antidepressant in Major Depressive Disorder: A Systematic Review of Randomized Controlled Trials
15. Role of mGlu receptors in psychiatric disorders –Recent Advances-
16. The involvement of monoaminergic neurotransmission in the antidepressant-like action of scopolamine in the tail suspension test
17. Serotonin transporter and receptor ligands with antidepressant activity as neuroprotective and proapoptotic agents
18. Neurochemical and behavioral studies on the 5-HT1A-dependent antipsychotic action of the mGlu4 receptor agonist LSP4-2022
19. Mutual activation of glutamatergic mGlu4 and muscarinic M4 receptors reverses schizophrenia-related changes in rodents
20. Safety profile of biologic drugs in the therapy of Crohn disease: A systematic review and network meta-analysis
21. The usefulness of monitored therapy using Clozapine concentration in the blood serum for determining drug dose in Polish schizophrenic patients
22. Antidepressant-like effects of scopolamine in mice are enhanced by the group II mGlu receptor antagonist LY341495
23. Metabotropic glutamate receptors as targets for new antipsychotic drugs: Historical perspective and critical comparative assessment
24. A novel mGlu4 selective agonist LSP4-2022 increases behavioral despair in mouse models of antidepressant action
25. mGlu5-GABAB interplay in animal models of positive, negative and cognitive symptoms of schizophrenia
26. Tetracycline-Based System for Controlled Inducible Expression of Group III Metabotropic Glutamate Receptors
27. Role of Neurotoxicity in Depression
28. Zinc deficiency in rats is associated with up-regulation of hippocampal NMDA receptor
29. Design and Synthesis of New Quinazolin-4-one Derivatives with Negative mGlu7 Receptor Modulation Activity and Antipsychotic-Like Properties
30. Metabotropic Approaches to Anxiety
31. Ionic Glutamate Modulators in Depression (Zinc, Magnesium)
32. Prolonged administration of antidepressant drugs leads to increased binding of [3H]MPEP to mGlu5 receptors
33. Lu AF21934, a positive allosteric modulator of mGlu4 receptors, reduces the harmaline-induced hyperactivity but not tremor in rats
34. Activation of the mTOR signaling pathway in the antidepressant-like activity of the mGlu5 antagonist MTEP and the mGlu7 agonist AMN082 in the FST in rats
35. Inhibitory actions of mGlu4 receptor ligands on cocaine-, but not nicotine-, induced sensitizing and conditioning locomotor responses in rats
36. Safety Profile of Biologic Drugs in the Treatment of Inflammatory Bowel Diseases: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials
37. Antibiotic consumption and antimicrobial resistance in Poland; findings and implications
38. Cost-utility analysis of 1-year treatment with adalimumab/standard care and standard care alone for ulcerative colitis in Poland
39. Disease activity, quality of life and indirect costs of psoriatic arthritis in Poland
40. Group II mGlu receptor antagonist LY341495 enhances the antidepressant-like effects of ketamine in the forced swim test in rats
41. Najwyżej cytowani badacze publikujący w dziedzinie farmakologia/farmacja i fizjologia oraz zatrudniające ich instytucje naukowe
42. Where do we go next in antidepressant drug discovery? A new generation of antidepressants: a pivotal role of AMPA receptor potentiation and mGlu2/3 receptor antagonism
43. Zinc, magnesium and NMDA receptor alterations in the hippocampus of suicide victims
44. Is the mGlu5 receptor a possible target for new antidepressant drugs?
45. Glutamate-Based Antidepressants: Preclinical Psychopharmacology
46. Zinc deficiency alters responsiveness to antidepressant drugs in mice
47. Anxiolytic- but not antidepressant-like activity of Lu AF21934, a novel, selective positive allosteric modulator of the mGlu4 receptor
48. mGlu2/3 and mGlu5 receptors: Potential targets for novel antidepressants
49. Neuronauka z neurologią i psychiatrią -- najczęściej cytowani polscy naukowcy i zatrudniające ich placówki.
50. Simultaneous alterations of brain and plasma serotonin concentrations and liver cytochrome P450 in rats fed on a tryptophan-free diet
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.